Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationThe Health Research Authority is seeking feedback to measure progress in improving study set up across the UK.
A new joint approval process aims to speed up patient access to innovative medicines in the UK.
The European Medicines Agency (EMA) Industry Highlights is a new quarterly newsletter for industry stakeholders providing updates on the latest regulatory and policy developments, with a focus on topics that directly impact industry and may require action.
The European Medicines Agency has released new guidance to support clinical trials during public health emergencies.
The US Food and Drug Administration has introduced a new tool to improve access to adverse event data.
The US Food and Drug Administration has published its latest CDER Guidance Agenda setting out potential guidance documents for drug regulation.
New analysis highlights the economic and healthcare benefits of expanding access to medicines through reclassification.
Singapore has become the first country to achieve the World Health Organization’s highest classification for medical device regulatory systems.
A new paper highlights the worldwide research impact of a major UK health data resource.
The International Medical Device Regulators Forum has opened a public consultation on new guidance for clinical evidence and performance evaluation of IVD medical devices.